268 related articles for article (PubMed ID: 18440125)
21. Renal angiomyolipoma with tuberous sclerosis complex: How it differs from sporadic angiomyolipoma in both management and care.
Hatano T; Egawa S
Asian J Surg; 2020 Oct; 43(10):967-972. PubMed ID: 31959574
[TBL] [Abstract][Full Text] [Related]
22. Laparoscopic and open partial nephrectomy: a matched-pair comparison of 200 patients.
Marszalek M; Meixl H; Polajnar M; Rauchenwald M; Jeschke K; Madersbacher S
Eur Urol; 2009 May; 55(5):1171-8. PubMed ID: 19232819
[TBL] [Abstract][Full Text] [Related]
23. Concomitant intraoperative renal artery embolization and resection of complex renal carcinoma.
Lin PH; Terramani TT; Bush RL; Keane TE; Moore RG; Lumsden AB
J Vasc Surg; 2003 Sep; 38(3):446-50. PubMed ID: 12947251
[TBL] [Abstract][Full Text] [Related]
24. [Spontaneous rupture of renal angiomyolipoma with tuberous sclerosis during long-term follow-up: a case report].
Hamaguchi T; Kasahara K; Shuin T; Kataoka S
Hinyokika Kiyo; 2001 Sep; 47(9):645-8. PubMed ID: 11692603
[TBL] [Abstract][Full Text] [Related]
25. Three-year oncologic and renal functional outcomes after robot-assisted partial nephrectomy.
Khalifeh A; Autorino R; Eyraud R; Samarasekera D; Laydner H; Panumatrassamee K; Stein RJ; Kaouk JH
Eur Urol; 2013 Nov; 64(5):744-50. PubMed ID: 23639721
[TBL] [Abstract][Full Text] [Related]
26. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
[TBL] [Abstract][Full Text] [Related]
27. Management of renal angiomyolipoma in complex clinical situations.
Khaitan A; Hemal AK; Seth A; Gupta NP; Gulati MS; Dogra PN
Urol Int; 2001; 67(1):28-33. PubMed ID: 11464112
[TBL] [Abstract][Full Text] [Related]
28. Selective arterial embolization of renal angiomyolipoma: comparing ethanol-lipiodol emulsion and polyvinyl alcohol particles as embolic agents.
Jin L; Chun HJ; Oh JS; Choi BG; Lee HG; Kim IJ
Diagn Interv Radiol; 2023 Jan; 29(1):170-174. PubMed ID: 36960593
[TBL] [Abstract][Full Text] [Related]
29. Varying Outcomes among Patients with Large Angiomyolipomas according to the Treatment Method.
Chan Park M; Park S; Kim SC; Park S; Moon KH; Cheon SH; Hwang JC; Kwon T
Urol Int; 2021; 105(7-8):680-686. PubMed ID: 33979804
[TBL] [Abstract][Full Text] [Related]
30. Elective and Emergency Renal Angiomyolipoma Embolization with Ethylene Vinyl Alcohol Copolymer: Feasibility and Initial Experience.
Urbano J; Paul L; Cabrera M; Alonso-Burgos A; Gómez D
J Vasc Interv Radiol; 2017 Jun; 28(6):832-839. PubMed ID: 28291715
[TBL] [Abstract][Full Text] [Related]
31. Outcomes of angioembolization and nephrectomy for renal angiomyolipoma associated with tuberous sclerosis complex: a real-world US national study.
Sun P; Liu J; Charles H; Hulbert J; Bissler J
Curr Med Res Opin; 2017 May; 33(5):821-827. PubMed ID: 28112545
[TBL] [Abstract][Full Text] [Related]
32. Sporadic versus Tuberous Sclerosis Complex-Associated Angiomyolipomas: Predictors for Long-Term Outcomes following Transcatheter Embolization.
Sheth RA; Feldman AS; Paul E; Thiele EA; Walker TG
J Vasc Interv Radiol; 2016 Oct; 27(10):1542-9. PubMed ID: 27522275
[TBL] [Abstract][Full Text] [Related]
33. Delayed haemorrhage after laparoscopic partial nephrectomy: frequency and angiographic findings.
Montag S; Rais-Bahrami S; Seideman CA; Rastinehad AR; Vira MA; Kavoussi LR; Richstone L
BJU Int; 2011 May; 107(9):1460-6. PubMed ID: 20831568
[TBL] [Abstract][Full Text] [Related]
34. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
[TBL] [Abstract][Full Text] [Related]
35. Embolization of renal angiomyolipomata in patients with tuberous sclerosis complex.
Williams JM; Racadio JM; Johnson ND; Donnelly LF; Bissler JJ
Am J Kidney Dis; 2006 Jan; 47(1):95-102. PubMed ID: 16377390
[TBL] [Abstract][Full Text] [Related]
36. Renal angiomyolipoma: optimal treatment based on size and symptoms.
Dickinson M; Ruckle H; Beaghler M; Hadley HR
Clin Nephrol; 1998 May; 49(5):281-6. PubMed ID: 9617489
[TBL] [Abstract][Full Text] [Related]
37. Factors associated with the number and size of renal angiomyolipomas in sporadic angiomyolipoma (sAML): a study of adult patients with sAML managed in a Dutch tertiary referral center.
Ruud Bosch JLH; Vekeman F; Duh MS; Neary M; Magestro M; Fortier J; Karner P; Ionescu-Ittu R; Zonnenberg BA
Int Urol Nephrol; 2018 Mar; 50(3):459-467. PubMed ID: 29333579
[TBL] [Abstract][Full Text] [Related]
38. [Long-term effect of transcatheter arterial embolization therapy for renal angiomyolipoma].
Sasaki M; Kawabata M; Asaji A; Takakuwa H; Ohta H; Kobayashi K; Matsui O; Kato Y
Nihon Jinzo Gakkai Shi; 1996 Jun; 38(6):273-7. PubMed ID: 8752970
[TBL] [Abstract][Full Text] [Related]
39. Conservative treatment of renal angiomyolipomas in patients with tuberous sclerosis.
Hadley DA; Bryant LJ; Ruckle HC
Clin Nephrol; 2006 Jan; 65(1):22-7. PubMed ID: 16429838
[TBL] [Abstract][Full Text] [Related]
40. Lessons learned from clinical outcome and tumor features of patients underwent selective artery embolization due to postoperative bleeding following 2076 partial nephrectomies: propensity scoring matched study.
Chung DY; Lee JS; Ahmad A; Chang KD; Ham WS; Han WK; Hong CH; Choi YD; Rha KH
World J Urol; 2020 May; 38(5):1235-1242. PubMed ID: 31346763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
